According to a new report published by Allied Market Research, titled, Global Enteral Nutrition Market by Material Type, Filter Module, and Application: Global Opportunity Analysis and Industry Forecast, 20182025, the global enteral nutrition market size was valued at $5,661.6 million in 2017, and is projected to reach $10,478.0 million in 2025, registering a CAGR of 7.9% from 2018 to 2025. Enteral nutrition is the administration of food supplements using pumps and tubes directly in the gastrointestinal tract of patients who cannot swallow food or get enough nourishment by eating or drinking. These medical devices deliver medications and nutrients directly into the stomach, duodenum, or jejunum either via nose, mouth, or direct percutaneous route.
Increase in prevalence of several chronic disorders such as cancer and neurological disorders worldwide, surge in adoption of enteral nutrition over parenteral nutrition, rise in geriatric population, and growth in malnutrition cases drive the market growth. However, stringent governmental regulations and inadvertent dislodgment of tubes leading to accidental disabilities and deaths impede the growth of the market. Conversely, the development of newer products with minimal side effects and presence of untapped market potential in the emerging economies are expected to provide lucrative growth opportunities for the global enteral nutrition market.
According to the WHO, the number of people diagnosed with diabetes increased from 108 million in 1980 to 422 million in 2014. In addition, the prevalence rate of diabetes in adults over 18 years of age increased from 4.7% in 1980 to 8.5% in 2014. This growth pattern is more evident in middle- and low-income countries. Thus, growing prevalence of diabetes fosters the growth of the enteral nutrition market.
As per the National Cancer Institute data, it is estimated that 1,735,350 new cases of cancer are expected to be diagnosed in the U.S. by the end of 2018. Moreover, according to the Centers for Disease Control and Prevention (CDC) data, about half of all adults (approximately 117 million) worldwide suffered from one or more chronic health conditions in 2012, while diabetes being the most common chronic disease. Therefore, burgeoning number of cancer cases across the globe are expected to increase the adoption of enteral feeding systems, thereby boosting the growth of the enteral nutrition market.
Globally, the geriatric population who are vulnerable to disorders such as cardiovascular, stroke, diabetes, gastric diseases, and intestinal illnesses has increased tremendously in the last few years. According to the data released by the U.S. Census Bureau, in 2015, about 617.1 million of the global population were in the age group of 65 years and above. The number of elderly people is expected to increase by 60% in just 15 years and is projected to grow further in the subsequent two decades. Rapid increase in geriatric population is one of the key drivers of the enteral nutrition market, as they are highly susceptible to various diseases due to decreased immunity and degeneration.
Enteral nutrition is preferred to parenteral nutrition due to improvements in safety and ease of access. In addition, usage of percutaneous jejunostomies, percutaneous dual tube gastrojejunostomies, and nasojejunal tubes has become common with good safety records. Therefore, it is highly acceptable as a home feeding therapy due to numerous advantages of enteral feeding.
The emerging economies of the Asia-Pacific region offer lucrative growth opportunities to the market players owing to improvement in healthcare infrastructure and increase in demand for better healthcare services in the region. Moreover, rise in prevalence of several chronic diseases in the developing countries fuels the demand for enteral nutrition. Moreover, increase in healthcare expenditure in these regions is projected to propel the enteral nutrition market growth.
Digital marketing is now preferred to conventional forms of advertising owing to the increased penetration of internet and social media. Mobile apps and social media are set to play a crucial role in assisting emerging markets, such as India, to catch up with the technical superiority of peer countries such as China.
Indian pharmaceutical companies have begun investing in the digital platform for marketing. In 2016, Sun Pharmaceuticals Industries Ltd., an Indian multinational pharmaceutical company launched its mobile app, RespiTrack, which has features such as medication reminders, pre-programmed alerts, over-the-air review by the doctor and others.
GlaxoSmithKline plc, a British pharmaceutical company equipped its employees with iPads to disseminate real-time information on the developments in therapy areas. In addition, the company used webinars, video chats, information portals, and platforms such as Viva for doctors to push sales.
Key Findings Of Enteral Nutrition Market :
- The protein for diabetes care patient segment by protein composition of enteral nutrition market is anticipated to witness the fastest CAGR of 9.4% from 2018 to 2025.
- The standard protein diet segment by protein composition dominated the global enteral nutrition market in 2017, and it is anticipated to grow at a lucrative CAGR of 7.2% during the forecast period.
- The online segment by distribution channel is anticipated to witness the fastest CAGR of 9.0% in terms of value during the forecast period.
- North America led the global enteral nutrition market in terms of value in 2017 and is anticipated to witness a CAGR of 7.1% during the forecast period.
- By form, the liquid segment dominated the enteral nutrition market in 2017 and is anticipated to witness a significant CAGR of 8.0% during the forecast period.
- The Asia-Pacific region is anticipated to witness the fastest CAGR of 8.8% in terms of value during the forecast period.
The major companies profiled in this report are Abbott Laboratories, Nestl S.A., Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Global Health Products, Inc., Meiji Holdings Co., Ltd., Victus, Inc., and Hormel Foods Corporation.